The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.EBI
Janssen Research and Development
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.EBI
Janssen Pharmaceutica
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.EBI
Janssen Pharmaceutica
Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.EBI
Janssen Pharmaceutica
[1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulatorsBDB
Janssen Pharmaceutica
6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereofBDB
Jiangsu Hengrui Medicine
Benzimidazole inhibitors of leukotriene productionBDB
Boehringer Ingelheim International
Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.BDB
Eli Lilly